Page 99 - Granted News Today

Cybin and Clinilabs Granted Schedule I DEA License for CYB003 Phase 1/2a First-In-Human Clinical Trial TORONTO, CANADA - August 17, 2022 - Cybin Inc. , a... | August 17, 2022

HELSINKI, Aug. 17 (Xinhua) -- The foreign ministers of Finland and Estonia met in Helsinki on Wednesday to discuss restrictions on visas for Russian citizens. P

HELSINKI, Aug. 16 (Xinhua) -- Finland is to reduce the availability of tourist visas to Russians to a tenth of the current numbers, Foreign Minister Pekka Haavi

AFP – Sri Lanka granted port access yesterday for a controversial Chinese research vessel despite neighbouring India’s concerns that it could spy on New Delhi’s military installations, officials said. The Yuan Wang 5 is described as a research and survey vessel by international shipping and analytics sites, but according to Indian media it is a […]

Relief Therapeutics Holding SA / Key word(s): Regulatory Admission Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in

Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancerSubmission

Opposing Raos bail plea, the National Investigation Agency (NIA) claimed before a bench headed by Justice U.U. Lalit that he is involved in

Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancer

By Chris Wack ATyr Pharma Inc. said Thursday that the U.S. Food and Drug Administration has granted the company Fast Track designation for its lead therapeutic candidate efzofitimod for the... | August 11, 2022

STOCKHOLM, SE / ACCESSWIRE / August 10, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 10 August 2022 - Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, have announced